These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 14594683

  • 21. [Prostatic cancer: an expensive dilemma].
    Borre M, Nerstrøm B, Overgaard J.
    Ugeskr Laeger; 1997 Apr 21; 159(17):2534-7. PubMed ID: 9182381
    [Abstract] [Full Text] [Related]

  • 22. The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.
    Sherman EJ, Pfister DG, Ruchlin HS, Rubin DM, Radzyner MH, Kelleher GH, Slovin SF, Kelly WK, Scher HI.
    Cancer; 2001 Feb 15; 91(4):841-53. PubMed ID: 11241254
    [Abstract] [Full Text] [Related]

  • 23. Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis.
    Wiréhn AB, Andersson A, Ostgren CJ, Carstensen J.
    Diabet Med; 2008 Jun 15; 25(6):732-7. PubMed ID: 18435778
    [Abstract] [Full Text] [Related]

  • 24. The economic consequences of asthma among adults in Sweden.
    Jansson SA, Rönmark E, Forsberg B, Löfgren C, Lindberg A, Lundbäck B.
    Respir Med; 2007 Nov 15; 101(11):2263-70. PubMed ID: 17689234
    [Abstract] [Full Text] [Related]

  • 25. Finasteride versus dutasteride: a real-world economic evaluation.
    Fenter TC, Runken MC, Black L, Eaddy M.
    Am J Manag Care; 2007 Feb 15; 13 Suppl 1():S23-8. PubMed ID: 17295602
    [Abstract] [Full Text] [Related]

  • 26. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
    Hagell P, Nordling S, Reimer J, Grabowski M, Persson U.
    Mov Disord; 2002 Nov 15; 17(6):1213-20. PubMed ID: 12465059
    [Abstract] [Full Text] [Related]

  • 27. The costs of cancer to a major employer in the United States: a case-control analysis.
    Barnett A, Birnbaum H, Cremieux PY, Fendrick AM, Slavin M.
    Am J Manag Care; 2000 Nov 15; 6(11):1243-51. PubMed ID: 11185849
    [Abstract] [Full Text] [Related]

  • 28. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach.
    Bolin K, Gip C, Mörk AC, Lindgren B.
    Diabet Med; 2009 Sep 15; 26(9):928-34. PubMed ID: 19719715
    [Abstract] [Full Text] [Related]

  • 29. [Screening of cancer of the prostate (IV). Economic approach: the costs of screening tests and treatment. Members of the Sub-Committee of the Prostate of CCAFU].
    Haillot O, Villers A, Soulie M, Baron JC.
    Prog Urol; 1998 Sep 15; 8(4):517-23. PubMed ID: 9834514
    [Abstract] [Full Text] [Related]

  • 30. Prostate cancer.
    Penson DF, Chan JM, Urologic Diseases in America Project.
    J Urol; 2007 Jun 15; 177(6):2020-9. PubMed ID: 17509282
    [Abstract] [Full Text] [Related]

  • 31. Healthcare costs associated with prostate cancer: estimates from a population-based study.
    Krahn MD, Zagorski B, Laporte A, Alibhai SM, Bremner KE, Tomlinson G, Warde P, Naglie G.
    BJU Int; 2010 Feb 15; 105(3):338-46. PubMed ID: 19594734
    [Abstract] [Full Text] [Related]

  • 32. Cost of depression in Europe.
    Sobocki P, Jönsson B, Angst J, Rehnberg C.
    J Ment Health Policy Econ; 2006 Jun 15; 9(2):87-98. PubMed ID: 17007486
    [Abstract] [Full Text] [Related]

  • 33. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M, Walker-Corkery E, Barry MJ.
    J Natl Cancer Inst Monogr; 2004 Jun 15; (33):78-101. PubMed ID: 15504921
    [Abstract] [Full Text] [Related]

  • 34. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR.
    Curr Med Res Opin; 2005 Feb 15; 21(2):195-206. PubMed ID: 15801990
    [Abstract] [Full Text] [Related]

  • 35. Societal cost of skin cancer in Sweden in 2005.
    Tinghög G, Carlsson P, Synnerstad I, Rosdahl I.
    Acta Derm Venereol; 2008 Feb 15; 88(5):467-73. PubMed ID: 18779884
    [Abstract] [Full Text] [Related]

  • 36. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH.
    Lung Cancer; 2005 Nov 15; 50(2):143-54. PubMed ID: 16112249
    [Abstract] [Full Text] [Related]

  • 37. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ, Scuffham PA, McCollam PL, Newby DE.
    Curr Med Res Opin; 2007 Mar 15; 23(3):495-503. PubMed ID: 17355731
    [Abstract] [Full Text] [Related]

  • 38. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I, Pintilie M, Potvin M, McGowan T.
    Can J Urol; 2004 Feb 15; 11(1):2125-32. PubMed ID: 15003151
    [Abstract] [Full Text] [Related]

  • 39. Prevalence and cost of musculoskeletal disorders: a population-based, public hospital system healthcare consumption approach.
    Osborne RH, Nikpour M, Busija L, Sundararajan V, Wicks IP.
    J Rheumatol; 2007 Dec 15; 34(12):2466-75. PubMed ID: 17985399
    [Abstract] [Full Text] [Related]

  • 40. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
    Hallert E, Husberg M, Jonsson D, Skogh T.
    Rheumatology (Oxford); 2004 Nov 15; 43(11):1374-82. PubMed ID: 15280570
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.